Expertise in
2
conditions

Alvaro N. Pinto

La Paz, MD, ES 
Expertise in
2
conditions
La Paz, MD, ES 

Overview

Alvaro Pinto practices practicing medicine in La Paz, Spain.

Mr. Pinto is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Orchiectomy, and Nephrectomy.

He is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

La Paz, MD, Spain
Other Locations
Madrid, MD 28046, Spain
La Paz, CN, Spain
Serrano, MD 28006, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Phase II Multicentre, Randomized, Open-label Study to Evaluate the Safety and Efficacy of Avelumab With Gemcitabine/Carboplatin Versus Gemcitabine/Carboplatin Alone in Patients With Unresectable or Metastatic Urothelial Carcinoma (UC) Who Have Not Received Prior Systemic Therapy and Who Are Ineligible to Receive Cisplatin-based Therapy.
Enrollment Status: Completed
Publish Date: October 18, 2023
Intervention Type: Combination product
Study Drugs: Avelumab 10mg/kg with Carboplatin/Gemcitabine, Carboplatin/Gemcitabine Alone
Study Phase: Phase 2
The DUTRENEO Trial: A Prospective Study to Individualize the Approach With DUrvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients.
The DUTRENEO Trial: A Prospective Study to Individualize the Approach With DUrvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients.
Enrollment Status: Completed
Publish Date: April 13, 2023
Intervention Type: Drug
Study Drugs: Durvalumab, Tremelimumab, Cisplatin, Gemcitabine, Methotrexate, Vinblastine, Doxorubicin, Paclitaxel
Study Phase: Phase 2
View 1 Less Clinical Trial

63 Total Publications

Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.
Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: June 22, 2026

Frequently Asked Questions about Alvaro N. Pinto

Is Alvaro N. Pinto a top-rated expert for Urothelial Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Alvaro N. Pinto is classified as an Advanced expert for Urothelial Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Alvaro N. Pinto participate in research or clinical trials?

Yes. Alvaro N. Pinto has published 63 articles and abstracts on conditions like Urothelial Cancer. You can view a list of Alvaro N. Pinto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Pinto's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile